An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors

NCT06076291 · clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
122
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hangzhou Sumgen Biotech Co., Ltd.